Search

Your search keyword '"Roche, Jean-Baptiste"' showing total 141 results

Search Constraints

Start Over You searched for: Author "Roche, Jean-Baptiste" Remove constraint Author: "Roche, Jean-Baptiste"
141 results on '"Roche, Jean-Baptiste"'

Search Results

1. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients

2. Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications

3. External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification

4. The impact of prostate volume estimation on the risk‐adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score

6. Experts’ recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group

9. Experts’ recommendations in laser use for the endoscopic treatment of prostate hypertrophy: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group

11. Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach

12. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging–Targeted and Systematic Biopsies: A European Multicenter Study

13. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy

14. Thulium: YAG vs continuous-wave thulium fiber laser enucleation of the prostate: do potential advantages of thulium fiber lasers translate into relevant clinical differences?

15. Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification

16. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy

17. MP29-13 APPLICATION OF THE STONE MANAGEMENT ACCORDING TO SIZE-HARDNESS (SMASH) SCORE IN THE SELECTION OF PATIENTS ELIGIBLE TO RETROGRADE INTRARENAL SURGERY (RIRS)

18. PD50-12 THE ADDED VALUE OF SIDE SPECIFIC SYSTEMATIC BIOPSY IN PATIENTS DIAGNOSED BY MAGNETIC RESONANCE IMAGING-TARGETED PROSTATE BIOPSY

19. Transperineal or Transrectal Magnetic Resonance Imaging–targeted Biopsy for Prostate Cancer Detection

21. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic

22. The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging–targeted Prostate Biopsy

24. Outcomes of Lateral Approach in Robot-Assisted Radical Prostatectomy: Insights from a Single-Surgeon experience

25. MP69-13 HOLMIUM:YAG VERSUS THULIUM:YAG LASER IN ENDOSCOPIC ABLATION OF UPPER TRACT UROTHELIAL CARCINOMA: A COMPARISON ON PERIOPERATIVE OUTCOMES AND SHORT-TERM FOLLOW-UP

26. PD28-11 A PROPOSED MATHEMATICAL MODEL TO HELP PREOPERATIVE PLANNING BETWEEN RIRS AND MINIPERC FOR RENAL STONES BETWEEN 10 AND 20 MM USING HOLMIUM:YAG LASER (CYBER HO): THE STONE MANAGEMENT ACCORDING TO SIZE-HARDNESS (SMASH) SCORE

27. MP13-12 A COMPARISON OF THE EFFICIENCY AND SAFETY PROFILE BETWEEN TWO MORCELLATORS FOR LASER ENUCLEATION OF THE PROSTATE: PIRANHA VERSUS CYBER BLADE DEVICES

28. Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions

29. Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining‐targeted biopsy

30. Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy

31. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy

32. Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging–targeted Biopsy?

33. Thulium: YAG vs continuous-wave thulium fiber laser enucleation of the prostate: do potential advantages of thulium fiber lasers translate into relevant clinical differences?

34. Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging–targeted Biopsy?

35. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy

37. Réflexions sur les biens communs

38. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.

39. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.

40. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients

41. Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications

42. External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.

43. External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy

45. Nomogram for Prediction of fatal outcome in Patients with Severe COVID-19: A Multicenter Study

46. External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study

47. A prospective multicenter randomized comparison between Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP)

48. Holmium Laser Enucleation of the Prostate With Virtual Basket Mode: Faster and Better Control on Bleeding

49. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic

50. “Vapor Tunnel”: Advantages of a New Setting Option for Urgent Holmium Laser Lithotripsy with Cyber-Ho

Catalog

Books, media, physical & digital resources